21 July 2020
Latham & Watkins Advises Tizona Therapeutics in Acquisition by Gilead Sciences
Advising firms
Deal team
19 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Mark Bekheit Lead | Latham & Watkins LLP | Partner | corporate | Bay Area |
| Brett Urig | Latham & Watkins LLP | Associate | corporate | Orange County |
| Michelle Lu | Latham & Watkins LLP | Associate | corporate | Bay Area |
| Raul Gonzalez | Latham & Watkins LLP | Associate | corporate | Bay Area |
| Christopher Lim | Latham & Watkins LLP | Associate | corporate | Bay Area |
| Judith Hasko | Latham & Watkins LLP | Partner | general corporate | Bay Area |
| Ben Potter | Latham & Watkins LLP | Partner | general corporate | Bay Area |
| Jekkie Kim | Latham & Watkins LLP | Associate | intellectual property | Bay Area |
| Peggy Ni | Latham & Watkins LLP | Associate | intellectual property | Bay Area |
| Ashley Wagner | Latham & Watkins LLP | Partner | benefits and compensation | Bay Area |
| James Robinson | Latham & Watkins LLP | Associate | benefits and compensation | Bay Area |
| Ben Haas | Latham & Watkins LLP | Partner | regulatory | Washington, D.C. |
| Nathan Beaton | Latham & Watkins LLP | Associate | regulatory | Not stated |
| Betty Pang | Latham & Watkins LLP | Counsel | healthcare and privacy | Bay Area |
| Heather Deixler | Latham & Watkins LLP | Counsel | healthcare and privacy | Not stated |
| Kirt Switzer | Latham & Watkins LLP | Partner | tax | Bay Area |
| Lauren Bewley | Latham & Watkins LLP | Associate | tax | New York |
| Mandy Reeves | Latham & Watkins LLP | Partner | antitrust | Washington, D.C. |
| Patrick English | Latham & Watkins LLP | Counsel | antitrust | Not stated |
16 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 300m ($300 million)
- What the figure measures
- Total transaction value
- Client
- Tizona Therapeutics Inc.Sell-side
- Counterparties
- Gilead Sciences, Inc. (Buy-side)